论文部分内容阅读
磺胺嘧啶钠是治疗流行性脑脊髓膜炎的首选药物,临床大多都采用较大剂量的SD—Na与葡萄糖注射液配伍静脉滴注。而且许多资料上的药物配伍禁忌表中标明SD—Na可以与葡萄糖注射液相配伍。我们实验几种不同浓度的葡萄糖注射液与不同浓度的SD—Na注射液(天律为民制药厂,批号780568)相配伍,观察到这些混合液在一定时间内均有不同程度的SD结晶析出。结果见表1、表2(显微镜观察为梭形棒状结晶) “一”表示无结晶“+”少量结晶,
Sulfadiazine sodium is the treatment of epidemic cerebrospinal meningitis drug of choice, most of the clinical use of larger doses of SD-Na and glucose injection compatibility with intravenous drip. And many data on the drug compatibility taboo table shows that SD-Na can be compatible with glucose injection. We experiment with several different concentrations of glucose injection with different concentrations of SD-Na injection (Tianli for the pharmaceutical company, lot number 780568) compatibility, observed that these mixtures have a certain degree of SD crystallization of a certain degree of time . The results are shown in Table 1, Table 2 (microscopic observation of fusiform rod-shaped crystals) “a” means no crystallization “+” a small amount of crystals,